In Depth 23 Aug 2022 Company’s 3D microchip gives mechanistic insights into human brain …tissue preparation because they cannot reach the necessary proximity to physiologically relevant cells. To tackle these challenges, 3Brain AG paired up with CSEM, a Swiss research and technology organization with… August 23, 2022 - 5 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Accelerated application for drug to help immunodeficiency submitted by Pharming …as a treatment for patients with APDS. First approved treatment “There is a significant unmet need for therapies to improve outcomes for these patients, which, if left untreated, can result… October 11, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jun 2020 Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost …While the mRNA-encoded antigens stimulate immune T cells to attack the tumor, the other mRNA molecule combination activates immune dendritic cells, which increase the strength of the attack. Similar to… June 18, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 24 Jul 2023 Sarcoma research: is a breakthrough in sight? …company is developing chimeric antigen receptors (CAR) T cells and bispecific antibodies that are designed to target LINGO1, using immune cells and tumor cells that have been taken from patients… July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 5 Nov 2018 DNA Repair Treatment Shows Early Promise for Treating Cancer …specific mutation or molecule being present in tumoral cells. The treatment has therefore potential to treat multiple types of tumors. “There will be obviously tumors for which the compound will… November 5, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin? …RNAs that code for mutant proteins that trigger ALS and Huntington’s disease, effectively silencing the mutant genes without disturbing the cell’s DNA. Meanwhile, another study conducted last year showed that… June 27, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 May 2024 8 Swedish companies spearheading the country’s biotech scene …The company says that daily, long-term treatment with BAMLET in the drinking water has been found to inhibit intestinal tumor development in mice genetically susceptible to intestinal tumors, compared to… May 28, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jul 2019 The Top 10 Biotechs You’ll Find in Lyon …of existing diabetes treatments. The company develops chaperone proteins that bind to a target drug, shielding it against degradation and enhancing its performance. The most advanced application of this technology… July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Apr 2023 New discovery “an area of cancer research with tremendous promise for breakthroughs” …technology to delete the ANKLE1 gene in human cells. During the process, the team discovered that the loss of ANKLE1 leads to increased formation of extended chromatin bridges, suggesting that… April 21, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2020 BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice …me. Like regular CAR T-cell immunotherapies, BioNTech’s treatment consists of genetically modifying T-cells to recognize a molecule linked to cancer cells. In the case of BioNTech’s therapy, the cells target… January 6, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Feb 2022 Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem …consists of extracting TILs from the patient and selecting those that target cancer neoantigens – mutated proteins that are only present in tumor cells. Achilles Therapeutics is currently running phase… February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 29 Oct 2020 Universal Flu Vaccines Yield Second Clinical Failure This Year …of immune T cells that are activated by the vaccine; particularly T helper cells — which play key support roles — and cytotoxic T cells, which destroy infected cells. “Based… October 29, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email